1. Home
  2. DMAC vs MED Comparison

DMAC vs MED Comparison

Compare DMAC & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMAC
  • MED
  • Stock Information
  • Founded
  • DMAC 2000
  • MED 1980
  • Country
  • DMAC United States
  • MED United States
  • Employees
  • DMAC N/A
  • MED N/A
  • Industry
  • DMAC Biotechnology: Pharmaceutical Preparations
  • MED Packaged Foods
  • Sector
  • DMAC Health Care
  • MED Consumer Staples
  • Exchange
  • DMAC Nasdaq
  • MED Nasdaq
  • Market Cap
  • DMAC 185.1M
  • MED 213.6M
  • IPO Year
  • DMAC N/A
  • MED N/A
  • Fundamental
  • Price
  • DMAC $4.23
  • MED $19.28
  • Analyst Decision
  • DMAC Strong Buy
  • MED Hold
  • Analyst Count
  • DMAC 3
  • MED 1
  • Target Price
  • DMAC $7.00
  • MED $17.00
  • AVG Volume (30 Days)
  • DMAC 34.2K
  • MED 178.3K
  • Earning Date
  • DMAC 11-13-2024
  • MED 11-04-2024
  • Dividend Yield
  • DMAC N/A
  • MED 33.20%
  • EPS Growth
  • DMAC N/A
  • MED N/A
  • EPS
  • DMAC N/A
  • MED 0.67
  • Revenue
  • DMAC N/A
  • MED $674,475,000.00
  • Revenue This Year
  • DMAC N/A
  • MED N/A
  • Revenue Next Year
  • DMAC N/A
  • MED N/A
  • P/E Ratio
  • DMAC N/A
  • MED $29.86
  • Revenue Growth
  • DMAC N/A
  • MED N/A
  • 52 Week Low
  • DMAC $2.12
  • MED $17.07
  • 52 Week High
  • DMAC $4.95
  • MED $76.42
  • Technical
  • Relative Strength Index (RSI)
  • DMAC 45.24
  • MED 56.99
  • Support Level
  • DMAC $4.14
  • MED $17.89
  • Resistance Level
  • DMAC $4.48
  • MED $21.08
  • Average True Range (ATR)
  • DMAC 0.18
  • MED 0.78
  • MACD
  • DMAC -0.03
  • MED 0.23
  • Stochastic Oscillator
  • DMAC 34.88
  • MED 56.49

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

About MED MEDIFAST INC

Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.

Share on Social Networks: